Army Medical Research and Development Command logo
Army Medical Research and Development Command

DoW Military Burn, Technology/Therapeutic Development Award

Funds turning preclinical burn-care findings into an actual product β€” a device, a drug, or a clinical practice guideline.

Between cyclesArmy Medical Research and Development CommandUnited States

A preclinical burn-care finding is not a product, and turning it into one β€” something a medic can actually use β€” is a distinct, costly stage that a lot of promising science never reaches.

This award funds that translation: turning promising preclinical findings into a burn product for clinical application in an austere, resource-limited, distributed operational environment. The product has to be …

Translating promising preclinical burn-care findings into a product-oriented outcome β€” a medical device, a drug, or a clinical practice guideline built around a therapeutic or technology β€” for clinical application in an austere, resource-limited, distributed operational environment. A knowledge product qualifies if it is applicable to a technology or therapeutic already under development.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Annual
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Cooperative agreement
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.$5M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides β†’
National Institute on Aging logo
Open

NIA Alzheimer's Drug-Development Program

πŸ‡ΊπŸ‡ΈNIA Β· United States

Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.

BiotechMedtech+1
Nov'27
National Institutes of Health logo
Open

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds the planning of a clinical trial in oral, dental or craniofacial health, and then running it, as one phased award.

BiotechMedtech
Jan'28
National Institutes of Health logo
Open

NIH StrokeNet Clinical Trials and Biomarker Studies for Stroke Treatment, Recovery, and Prevention

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds stroke trials and biomarker studies run inside NIH's national StrokeNet β€” with its coordinating centres doing recruitment and data.

MedtechBiotech
Nov'26
National Institutes of Health logo
Open

First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds the first human trials of a novel-mechanism psychiatric drug or a novel neuromodulatory device, with milestones gating each step.

BiotechNeurotech+1
Oct'27
National Institutes of Health logo
Open

NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3)

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds the implementation of a clinical trial in arthritis, musculoskeletal or skin disease as a phased cooperative agreement with the institute.

BiotechMedtech
Mar'27
NIH Common Fund logo
Open

Complement-ARIE β€” Open Funding (Seed)

πŸ‡ΊπŸ‡ΈNIH Common Fund Β· United States

Supports development of human-based new approach methodologies replacing animal models in relevant research.

BiotechMedtech+1